Treatment Information

Back

Breast Cancer treatment details. Chemotherapy, Biologic therapy.

Dicle University School of Medicine, Diyarbakir, Turkey.

Survival: monthsCountry:Turkey
Toxiciy Grade:4City/State/Province:Diyarbakir
Treatments:Chemotherapy, Biologic therapyHospital:Dicle University School of Medicine
Drugs:Journal:Link
Date:Nov 2014

Description:

Patients:
This study involved 46 previously treated HER2-positive metastatic breast cancer patients who had brain metastasis. The median patient age at the time of diagnosis was 45 years.

Treatment:
Patients received biologic therapy with lapatinib (a tyrosine kinase inhibitor) and chemotherapy with capecitabine.

Toxicities:
The most severe toxicities were of grade 4 and included grade 3-4 hand-foot skin reaction, nausea/vomiting, and diarrhea.

Results:
The median overall survival was 19.1 months.

Correspondence: Dr. Muhammet Ali Kaplan; email: [email protected]



Back